These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 1768565

  • 1. Exercise performance during captopril and atenolol treatment in hypertensive patients.
    Van Baak MA, Koene FM, Verstappen FT, Tan ES.
    Br J Clin Pharmacol; 1991 Dec; 32(6):723-8. PubMed ID: 1768565
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular response to dynamic treadmill exercise in patients with essential hypertension before and after therapy with atenolol or captopril.
    Shah PK, Lakhotia M, Chittora M, Mehta S, Mehta S, Vyas R, Parihar M.
    J Assoc Physicians India; 1990 Oct; 38(10):781-4. PubMed ID: 2084084
    [Abstract] [Full Text] [Related]

  • 3. Comparative efficacy of captopril and atenolol in moderately severe essential hypertension.
    Carey M, Blake S.
    Postgrad Med J; 1986 Oct; 62 Suppl 1():111-2. PubMed ID: 3317338
    [Abstract] [Full Text] [Related]

  • 4. [Effects of captopril on hemodynamics, gas exchange and exercise capacity in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease].
    Paitl CE, Nery LE, Romaldini H, Herrmann JL, Portugal OP, dos Santos ML, Martinez Filho EE.
    Arq Bras Cardiol; 1989 Feb; 52(2):59-67. PubMed ID: 2688602
    [Abstract] [Full Text] [Related]

  • 5. The effects of antihypertensive medications on the physiological response to maximal exercise testing.
    Derman WE, Sims R, Noakes TD.
    J Cardiovasc Pharmacol; 1992 Feb; 19 Suppl 5():S122-7. PubMed ID: 1381788
    [Abstract] [Full Text] [Related]

  • 6. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
    Saner H, Seiler A, Mahler F.
    Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
    [Abstract] [Full Text] [Related]

  • 7. Effects of atenolol withdrawal in patients on triple antihypertensive therapy.
    Bevan EG, Pringle SD, Waller PC, Herrick AL, Findlay JG, Murray GD, Carmichael HA, Lorimer AR, Reid JL, Weir RJ.
    J Hum Hypertens; 1993 Feb; 7(1):89-93. PubMed ID: 8450527
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of transdermal clonidine and oral atenolol on acute exercise performance and response to aerobic conditioning in subjects with hypertension.
    Davies SF, Graif JL, Husebye DG, Maddy MM, McArthur CD, Path MJ, O'Connell MB, Iber C, Davidman M.
    Arch Intern Med; 1989 Jul; 149(7):1551-6. PubMed ID: 2525897
    [Abstract] [Full Text] [Related]

  • 9. Captopril compared to atenolol in mild to moderate hypertension in a randomized double-blind controlled trial.
    Havinga TK, ten Berge BS, May JF, Schuurman FH, van der Veur E, Wesseling H.
    Neth J Med; 1991 Feb; 38(1-2):13-7. PubMed ID: 2030804
    [Abstract] [Full Text] [Related]

  • 10. Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man.
    Frisk-Holmberg M, Juhlin-Dannfelt A, Aström H.
    Clin Physiol; 1985 Jun; 5(3):231-42. PubMed ID: 2860992
    [Abstract] [Full Text] [Related]

  • 11. Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy).
    Gerdts E, Björnstad H, Devereux RB, Lund-Jhansen P, Davidsen ES, Omvik P.
    Blood Press; 2006 Jun; 15(4):220-6. PubMed ID: 17060116
    [Abstract] [Full Text] [Related]

  • 12. [Effectiveness of atenolol in moderate arterial hypertension. Evaluation by stress test].
    Arrieta JA, Alegría E, Huguet R, Larraz MP, Calabuig J, Martínez Caro D.
    Rev Med Univ Navarra; 1987 Jun; 31(1):23-8. PubMed ID: 3616360
    [Abstract] [Full Text] [Related]

  • 13. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH, Davies RA, Fourney A.
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [Abstract] [Full Text] [Related]

  • 14. Physical performance and muscle metabolism during beta-adrenergic blockade in man.
    Kaiser P.
    Acta Physiol Scand Suppl; 1984 Nov; 536():1-53. PubMed ID: 6151777
    [Abstract] [Full Text] [Related]

  • 15. Integrated effects of the vasodilating beta-blocker nebivolol on exercise performance, energy metabolism, cardiovascular and neurohormonal parameters in physically active patients with arterial hypertension.
    Predel HG, Mainka W, Schillings W, Knigge H, Montiel J, Fallois J, Agrawal R, Schramm T, Graf C, Giannetti BM, Bjarnason-Wehrens B, Prinz U, Rost RE.
    J Hum Hypertens; 2001 Oct; 15(10):715-21. PubMed ID: 11607802
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Assessing the effect of exercise training in men with heart failure; comparison of maximal, submaximal and endurance exercise protocols.
    Larsen AI, Aarsland T, Kristiansen M, Haugland A, Dickstein K.
    Eur Heart J; 2001 Apr; 22(8):684-92. PubMed ID: 11286526
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive therapy and quality of life: a comparison of atenolol, captopril, enalapril and propranolol.
    Steiner SS, Friedhoff AJ, Wilson BL, Wecker JR, Santo JP.
    J Hum Hypertens; 1990 Jun; 4(3):217-25. PubMed ID: 2194029
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.